Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis

BACKGROUND: Viral- and host-targeted traditional Chinese medicine (TCM) formulae NRICM101 and NRICM102 were administered to hospitalized patients with COVID-19 during the mid-2021 outbreak in Taiwan. We report the outcomes by measuring the risks of intubation or admission to intensive care unit (ICU...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yu-Hwei, Lin, Sunny Jui-Shan, Hou, Sheng-Mou, Wang, Chih-Hung, Cheng, Shun-Ping, Tseng, Kung-Yen, Lee, Ming-Yung, Lee, Shen-Ming, Huang, Yi-Chia, Lin, Chien-Jung, Lin, Chi-Kuei, Tsai, Tsung-Lung, Lin, Chen-Shien, Cheng, Ming-Huei, Fong, Tieng-Siong, Tsai, Chia-I., Lu, Yu-Wen, Lin, Jung-Chih, Huang, Yi-Wen, Hsu, Wei-Chen, Kuo, Hsien-Hwa, Wang, Li-Hsiang, Liaw, Chia-Ching, Wei, Wen-Chi, Tsai, Keng-Chang, Shen, Yuh-Chiang, Chiou, Wen-Fei, Lin, Jaung-Geng, Su, Yi-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395232/
https://www.ncbi.nlm.nih.gov/pubmed/36007774
http://dx.doi.org/10.1016/j.phrs.2022.106412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395232/
https://www.ncbi.nlm.nih.gov/pubmed/36007774
http://dx.doi.org/10.1016/j.phrs.2022.106412

Ejemplares similares